Description
A sphingolipid; acts as a receptor for Shiga toxin in B cell-derived Raji cells and THP-1 monocytes; accumulates in various cells in patients with Fabry disease; upregulated in plasma of patients with ovarian carcinoma compared to those with benign ovarian tumors or uterine fibroids,,
Formal name: N-[(1S,2R,3E)-1-[[(O-α-D-galactopyranosyl-(1→4)-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-hexadecanamide
Synonyms: C16 Ceramide Trihexoside (d18:1/16:0)|Gb3 (d18:1/16:0)
Molecular weight: 1,024.30
CAS: 137896-85-6
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Cancer||Research Area|Endocrinology & Metabolism|Inborn Errors of Metabolism||Research Area|Immunology & Inflammation|Adaptive Immunity||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Infectious Disease|Bacterial Diseases|Shigellosis||Research Area|Lipid Biochemistry|Sphingolipids